michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. I think it was never the case. I don't know if it's no longer the case. Again, the way that we price is -- or the fair system that we found to monetize our platform, I think it's very competitive.
I think in certain cases, you'll see it's more expensive than the competition. In some cases, you'll see the competition actually coming in and discounting deeply to try and win against us. I think the dynamics in our market are very account and sales cycle-dependent. As a whole, again, if you look at our entire business, PPN is on the rise.
We like our price point. Look at our margin. I mean, that would not have been possible without a very healthy price point for our offering. So, to us, I mean, it's incredibly healthy.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I think, let me start. On Walmart, you can finish it. Well, we are very happy with Walmart, right? We enrolled 4,700 locations in the U.S. As you recall, we already were active with Walmart in Canada and in Mexico. And the performance is picking up and good performance, and we start our marketing activities. If you have time to go to Walmart location, you will see Western Union everywhere there. And I think [Indecipherable] associates has been trained and many customers start to use us through many corridors, and we are gaining customers from Walmart to our network. So that's great.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Another really good question. So if we think about the first two weeks of AEP, we had the positives of a lot of follow-up meetings that our agents have set during the SEP time frame where consumers weren't eligible to enroll during SEP. So a lot of those kind of calls happened during the first couple of weeks of AEP, which gave us a very high -- but those calls tend to close a lot faster because our agents have already made the relationship with that consumer.
So that was kind of one factor. The second factor, you're right, the election was not over on election day, and those trends continue on. And I think that also was a little bit hard to forecast as we thought about that kind of going into AEP.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Go ahead, Steve. Yeah, just very quickly, we're watching our later cycle businesses very carefully. Those who lack control, sort of control, you know which ones they are. They -- project-based businesses which have good and lag coming into the down cycle. So Ram was still experiencing solid growth at this point last year. And having weakened, and and so we'll see him come in a little bit later. So that's going against us as well.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
They always ebb and flow, Matthew. We're -- I'm actively reaching out to folks and discussing how it might make sense for us to partner. But as I said in my prepared comments, we have been a disciplined acquirer. That is going to continue. That just will not change. We've demonstrated very clearly our ability to create value for our shareholders and the collective shareholders when folks partner with us and we're not going to do anything that's going to change that fact.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, Charles. Yeah, we are not providing any guidance yet. Thank you for your questions, by the way. We still think that we need to monitor what's happening with COVID before we are able to provide any guidance at this point. So, you know that our policy is, at this point, no guidance. And with regard to our shortening the diagnostic journey, I will let Jeff answer that versus the prevalence as we both mentioned in our remarks, it is a little bit more difficult these days. We have tools in place to shorten that journey. But the real issue is at the physician's offices where there -- a lot of them are not fully functional at this point or they're not checking new patients, or they are requiring several in-person visits, before they will prescribe a new medication. So, those are some of the dynamics that we are dealing with, and one of the reasons why we are at this point, unwilling to provide a revenue guidance. So Jeff, do you want to talk about the diagnostic journey and the tools we are using?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, we're seeing, John, good acceleration in the underlying process. We went through a period of time, as you'll recall, of break/fix environment with limited site access, with limited STO type of activity. That's flipped. Obviously, the inoculation rates in this country have helped the confidence that customers have in having others on site and having their own folks, very honestly, on site.
That's driven now a level of activity that is incredibly encouraging and is, I think, above and beyond just the simple comparisons that we have. The discrete strength, to your point, will remain. I don't foresee that to wane at least as we go through the year in North America, but the real fuel there will be increased activity. And we're seeing that in the PO rates. We're seeing that in quotation activity and in the daily booking activity in our short to medium cycle automation businesses.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Look at the media. I mean, John, you could probably comment better than I can.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
All right, Mitch. Thank you.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Shay. Hey, Janesh. Thanks for taking my questions. Got a couple for you.
The first one on the Elastic App Search web crawler announcement. With it becoming GA and the 7.15 release, I was wondering if you could talk a little bit about how fast that can get enterprise search up and running versus how it was done in the past. And when I first saw the release back at the end of September, reading the blog post, I thought that there could be many different use cases for this type of crawler within an organization. I was wondering if that thought process was right.
Could this crawler be used for anywhere within an organization where data is being updated continuously like an e-commerce search or maybe in an internal workplace or a self-service technology base? And then I have one follow-up.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Jim, do you want to add, at the top your head?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, good morning everyone. Just back on the fourth quarter, and I do apologize if I missed it maybe, Jerome. But did you quantify the engineering impact in the fourth quarter? I think you mentioned it should be going higher versus Q3.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sustained.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. So, I think in total, when we look at the year and as we're heading into 2021, just as when we were headed into 2020, we targeted and we talked about a year ago in a lower growth environment we were targeting to hold margins and that would still be our expectation this year for in a lower growth environment, continue to target holding margins.
When you think, just like you said, across the company, the range of our guidance assumptions includes a number of different factors depending on the environment and the macro. We would start -- expect to see certainly when you look at the second quarter when we had the trough in some of the businesses, it had a margin impact there. We would expect to see a larger recovery, particularly in Q2.
When we look more broadly, as you know, when we've talked about in the past, our overall focus over time is balancing our top line growth with strong margins and strong capital efficiency in order to drive long-term growth in EVA. And that's how we'll continue to think about it. So, margins continues to be a big factor, of course, and continuing to drive margins, but we're looking at the balance of those two things to drive long-term EVA growth over time.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We think traffic is going to come back at Dollar Tree. Keep in mind, as Kevin said, with our -- we still have past dues that are 4.5 times greater than what we normally have at Dollar Tree. So there is inventory that we wish we had that would drive that excitement in sales and traffic inside our Dollar Tree. And then we have had some items we've had to discontinue that would be traffic-driving where we were limited at the Dollar price points.
So we think looking forward going to the $1.25, bringing in new assortment and then once we move beyond this transitory freight logistics issues that we have, getting that assortment that we want inside our store, the combination of those two things will get back to driving traffic at our Dollar Tree format.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I think it's both, honestly. Clearly, we're working with our suppliers. I guarantee you, everybody in bioprocessing is working with their suppliers. But, you never know, right, as you go from quarter to quarter what unexpected supply issues crop up. You just have to manage through it. I think, in general, the supplier side has been well managed. We worked through any issues that need to get worked through.
I think the internal capacity and lead times, we've obviously for the last two years has been building out, and that's helped us a lot, honestly, second half of last year and first half of this year. We also realize that we need to have more capacity and that's why we're spending the $55 million to $60 million this year and there'll be a significant spend next year as we add capacity in the second half of this year and we add capacity in 2022. And all of that puts us in a position to be able to support a $1 billion-type company by 2025.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I mean a couple of things, Josh. Thanks for the question. Again, we feel pretty -- we feel good about what we've seen from a marketplace in terms of the activity that's out there. The ARR growth is good as we think about sort of the quarter and we think about the growth in the quarter and as it translates into guidance.
A couple of things first, keep in mind services does take a little bit of a dip in the first quarter. We have real strong -- we had a real strong Q4 from a services standpoint with customers trying to get some year-end implementations up and running. So, that was really good for us. Again, on the backside of that sort of drops a little bit from a total revenue standpoint from, you know, from an invoicing standpoint when we take a look at, you know, at 2020, we had a really nice.
And -- and there were some -- there were some anomalies a little bit in Q4, as I had mentioned, some of that transaction-based pricing true-ups that happened in the fourth quarter not giant but certainly impacting as we move forward. So, we continue to see momentum, you know, from -- from a, you know, from a revenue standpoint that continues to grow. But again some of the -- some of the activity and a little bit of the slowness and some of that push out that I talked about in my remarks that we saw in 2020 sort of manifest itself in revenue sort of as it rolls into 2021. That's how I would summarize it.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Look, look, as you know, it is summer of next year. And so like it's hard to make a call about your capital 18 months from now. And again, you have the ability to flex settle, which I think is helpful. So it's not binary. And so I just -- it's hard to make a call 18 months. We obviously understand those levers very well, which is all things being equal, you rather do something with the converse as accretive, the net asset value than dilutive.
And so yes, if you had perfect visibility would you like to run a little bit hot, knowing that you can settle in stock and the answer would be yes. But again, I think that's some time off, we're going to have a lot of -- we'll have more visibility. The good news with time and nature of time, as time passes you get more clarity. And so -- but we most definitely understand those levers, and we'll -- as we do with everything, we'll be thoughtful as it relates to our shareholders.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. So one of the reasons we're excited about DTCA in general is that, it's not just a growth lever, we think of it as a margin lever as well. It is, we expect higher VMM margin as we go deeper with the consumer in terms of the value of the transaction, and then over time as well, we expect it to be a higher EBITDA business as well. So we think it's both unlocking growth, as well as margin potential.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great, Thanks for taking my questions. First on VoiceBase and Tenfold, you're going pretty quick on this what you're expecting in terms of the contribution on revenue and EBITDA for Q4. And can you just put it in a broader context, how big there, how many heads and what you're thinking in the out year?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So to give you some sense Jack on what -- on how that order book is going to flow through. I mean we saw at Cytiva and Pall Biotech in the second half of the year -- we grew -- call it north of 35%. We've got that backlog position now and some of the -- some of what you said, for some of that came in during the year and booked and shipped in the year to give us 35% but we're going to get off to a pretty good start here at Cytiva Q1 core growth in Cytiva is going to be probably north of 50%.
So I think we'll have a good strong start. Let's see how that order book sort of develops through the year as more vaccines in therapeutic, sort of, make their way through the systems to the approvals -- but that's sort of how we've framed it as we stand now with kind of the $1.3 billion opportunity Part 6

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. Good morning. Just wanted to start with the Automation Solutions organic growth guide. So you're assuming that, that business grows about 7% this quarter and then the same over the subsequent three quarters even as the comps get a lot more difficult. So I just wanted to understand, is sort of everything in that segment steady state as you go through the year in terms of hybrid versus process versus discrete or KOB one, two and three? Or is there something changing across either of those axes kind of as you move through the year that allows the organic growth rate to hold steady even with tougher comps?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. You're welcome. Thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So we are delighted to see lecanemab coming along strong with a reach that base after ADUHELM, more than 600 patients, but it's only Phase 2. So we need to see the Phase 3. But certainly very positive and reinforcing underlying motor function and seeing those, we'll have the opportunity and the luxury to have two assets. Importantly, I want to reiterate that we stand by the data for ADUHELM because we know the data, we see the data, we see the new data and we are very confident in the profile and the benefit risk of these products for the long run. Now with leca, it's even a stronger position. But we need to wait for additional data. Al?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Maybe Denise, you could take the strength. And I'll take what's going to happen going forward.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Thanks, Jeff. We should. And I think what you've seen in North America if you look at the -- the booking pace for invoiced sales over the last six quarters, pre-pandemic it was higher than 10% and it has been in recent quarters as well. So I think ultimately that drives that top line growth in the All Access Pass and related being high will ultimately -- should ultimately of course could pull the overall average up for some years as you noted, we've had offsetting that growth with some decline in the historic legacy business that's now as you pointed out on the flatter part of that curve and so as All Access Pass and related continues. Well, I think our point is we think we can achieve $10 million a year of EBITDA growth if we only grow in the high single digits because of the 50% flow through, but to the extent we got higher revenue growth and your point to one that we obviously believe that could be a bit better.

    Prediction (one of UP, DOWN, SAME): UP